FTC Requires Divestiture of Two Medical Device Product Lines as Condition of Becton, Dickinson and Company Acquiring C. R. Bard, Inc.
Date
Becton, Dickinson and Company and C. R. Bard, Inc. have agreed to divest two medical device product lines to settle Federal Trade Commission charges that Becton, Dickinson’s proposed $24 billion...